Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Relation Between Plasma Soluble Urokinase Plasminogen Activator Receptor and Behçet's Disease .

NCT04105439 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT04105439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04105439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Relation Between Plasma Soluble Urokinase Plasminogen Activator Receptor and Behçet's Disease .
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2021
Completion date
December 1, 2021
Enrollment
90 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

behçet disease